S&Co Inc Eli Lilly & CO Transaction History

S&Co Inc

$1.53 Billion
Q3 2024

A detailed history of S&Co Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, S&Co Inc holds 6,110 shares of LLY stock, worth $4.85 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

6,110

Previous 6,150 0.65%

Holding current value

$4.85 Million

Previous $5.57 Million 2.78%

% of portfolio

0.35%

Previous 0.39%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $30,885 - $38,400	-40 Reduced 0.65%	6,110 $5.41 Million
Q2 2024 Aug 08, 2024	SELL	$724.87 - $909.04 $380,556 - $477,246	-525 Reduced 7.87%	6,150 $5.57 Million
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $681,030 - $911,122	-1,150 Reduced 14.7%	6,675 $5.19 Million
Q4 2023 Feb 12, 2024	SELL	$525.19 - $619.13 $351,877 - $414,817	-670 Reduced 7.89%	7,825 $4.56 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $12,275 - $16,414	-35 Reduced 0.41%	8,495 $3.98 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $35,722 - $41,954	-115 Reduced 1.33%	8,530 $2.93 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $4,823 - $5,620	-15 Reduced 0.17%	8,645 $3.16 Million
Q3 2022 Nov 09, 2022	SELL	$296.48 - $337.87 $23,718 - $27,029	-80 Reduced 0.92%	8,660 $2.8 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $13,936 - $16,363	-50 Reduced 0.57%	8,740 $2.83 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $11,080 - $13,635	-50 Reduced 0.57%	8,790 $2.03 Million
Q3 2020 Dec 11, 2020	SELL	$146.22 - $169.13 $22,664 - $26,215	-155 Reduced 1.72%	8,840 $1.31 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $693,244 - $769,432	8,995	8,995 $769,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S&Co Inc, based on Form 13F filings with the SEC.

News

Stay updated on S&Co Inc with notifications on news.

Account